Forwarding tests, involving Western blotting and quantitative reverse-transcription polymerase chain reaction analysis provided further evidence that miR-34a was instrumental in cutting the expression of PDGFRA in colon cancer cells. The gene discussed is PDGFRA; the disease is colonic neoplasm.